ESR1 and endometrial cancer: The differential subtype effects reflect distinct biological pathways: cervical adenocarcinoma demonstrates estrogen-receptor positivity like endometrial cancer, while squamous cell carcinoma benefits from enhanced immune surveillance, which is a high-risk factor for epithelial cell related cancer (28, 29).